Radiomics Shows Promise for Cardiotoxicity Detection in Cancer Patients, but Validation Lacking

Radiomics, extracting quantitative features from routine imaging, shows promise for real-time detection and prediction of cancer therapy-related cardiotoxicity. However, current evidence is limited by small, non-externally validated studies. A paradigm shift in cardio-oncology i…

• This is a narrative review exploring radiomic signatures across imaging modalities for cardiotoxicity detection and prediction.
• The emerging field is currently limited by small studies lacking external validation.
• Radiomics may enable personalized risk stratification, but robust prospective validation is needed before clinical adoption.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.